Mutant Prevention Concentration of Ciprofloxacin against Klebsiella pneumoniae Clinical Isolates: An Ideal Prognosticator in Treating Multidrug-Resistant Strains
Background. Fluoroquinolone-resistant Klebsiella pneumoniae poses a therapeutic challenge when implicated in urinary tract infections, pyelonephritis, pneumonia, skin infections, osteomyelitis, and respiratory infections. The mutant prevention concentration (MPC) represents a concentration threshold...
Main Authors: | B. Aditi Priyadarshini, Krishnan Mahalakshmi, Venkatesan Naveen Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | International Journal of Microbiology |
Online Access: | http://dx.doi.org/10.1155/2019/6850108 |
Similar Items
-
Envelope permeability and multidrug resistance in Klebsiella pneumoniae
by: Kamil, Wan Nur Ismah Binti Wan Ahmad
Published: (2018) -
Andrographis paniculata extract inhibit growth, biofilm formation in multidrug resistant strains of Klebsiella pneumoniae
by: Saroj Kumar Sah, et al.
Published: (2020-11-01) -
In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01) -
Postoperative endophthalmitis due to multidrug-resistant Klebsiella pneumoniae treated successfully with intravitreal colistin and core vitrectomy
by: Amit Kumar Deb, et al.
Published: (2020-01-01) -
Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae.
by: Fangqing Zhao, et al.
Published: (2010-01-01)